Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tan Wang
Observed name:
T. Wang
Institutions:
Changchun University of Chinese Medicine,
The Affiliated Hospital to Changchun University of Chinese Medicine
Observed institutions:
Changchun University of Chinese Medicine,
The Affiliated Hospital to Changchun University of Chinese Medicine
ORCID:
0000-0002-9368-1874
Observed ORCID:
0000-0002-9368-1874
OpenAlex ID:
A5090298518
Lactylation modification in lung cancer: A review of current research and future directions (Review)
2025
·
Qingguo Lv
, Jianan Xu
, et al.
·
Oncology Reports
·
6
PDF
Integration of circulating biomarkers and clinical factors: construction and validation of a prediction model for lung cancer metastasis
2025
·
Wenlong Qi
, Zhenyu Li
, et al.
·
BMC Pulmonary Medicine
·
3
PDF
Efficacy and safety of Xiao-ai-ping injection add-on therapy to chemotherapy in patients with non-small cell lung cancer: A systematic review and meta-analysis
2023
·
Andong Li
, Shilin Liu
, et al.
·
Medicine
·
2
A randomized, two-arm, phase II trial assessing the efficacy and safety of anthracycline or carboplatin plus docetaxel and tratuzumab as neoadjuvant treatment in HER2-positive breast cancer and prognosis of CTC
2017
·
T. Wang
, J. Zhou
, et al.
·
The Breast
PDF
Show more works
View as search
Works count:
4
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type